Skip to main content
. 2000 Jan;13(1):67–82. doi: 10.1128/cmr.13.1.67-82.2000

TABLE 2.

Susceptibility of YFV and DENV to a selection of antiviral agents

Antiviral agent EC50 (μg/ml)a for:
YFV DENV
Ribavirin 28 ± 18 49 ± 13
EICAR 0.8 ± 0.6 2.4 ± 0.8
Mycophenolic acid 0.08 ± 0.05 0.4 ± 0.3
Tiazofurin 25 ± 14 98 ± 13
Selenazofurin 3.6 ± 1.5 10 ± 5.7
a

Concentration required to reduce the virus-induced cytopathic effect in Vero cells by 50%. 

HHS Vulnerability Disclosure